WIA
TEVA icon

World Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

World Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
7,231
-643
-8% -$21.4K ﹤0.01% 1424
2026
Q1 		$237K Buy
+7,874
New +$253K ﹤0.01% 1400

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

World Investment Advisors's TEVA Position: Q2 2026 in Review

World Investment Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 8.2% in Q2 2026, selling an estimated $21.4K and leaving 7,231 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

World Investment Advisors first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $237K in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • World Investment Advisors held 7,231 shares of Teva Pharmaceuticals worth $218K as of Q2 2026.
  • World Investment Advisors sold 643 Teva Pharmaceuticals shares in Q2 2026, an estimated $21.4K.
  • Teva Pharmaceuticals made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1424 holding.
  • World Investment Advisors first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • World Investment Advisors's Teva Pharmaceuticals position peaked at $237K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.